The control of immune system after a transplant is crucial to ensure the survival not only of the graft but also of the transplant patient. The advances in immunosuppression, histocompatibility and surgical techniques have been responsible for the success achieved in the kidney transplant at early-term post-transplantation. However, the risk of graft loss remains very high in the medium and long-term (50% in the tenth-year post-transplantation).

An Italian partnership is working on the proposal "Supporting long term integration and empowerment of third-country nationals under the AMIF-2020-AG-CALL-02 "Reducing obstacles and promoting access to basic services for third-country nationals". Currently, the partnership is led by an Italian non-profit SME, based in the south of Italy, and working since 1989 in the fields of inclusion, education, cooperation and local development, with a consolidated experience in the delivery of targeted services as well as in the identification of policies and good practices at regional an

An innovative Turkish company founded in 2013 and operated in Ankara, focuses on additive manufacturing and 3D printing technologies as a result of its no geometry boundaries philosophy. The company aims to replace metal or polymeric implants with biodegradable alternatives that also have the ability to deliver drugs in a controlled fashion at the defect site. Many patients need craniomaxillofacial implants as a result of work accidents, congenital deficiencies and diseases like cancer.

A Turkish biomedical company founded in 1991 and operated in Ankara, produces medical equipment for hospitals, health institutions, and organizations and establishing full-scale installations. The company aims to provide solutions in order to present a healthy life to humanity under our statement of technologies for life, taking advantage of cutting-edge advancements in line with the international standards in the healthcare sector.